Close

Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data

Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 23.38 +0.51 (2.23%)
Previous Close $22.87    52 Week High $17.00 
Open $23.02    52 Week Low $3.55 
Day High $23.44    P/E N/A 
Day Low $23.00    EPS $-1.33 
Volume 574,283